Patents by Inventor Peter G. Carroll

Peter G. Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR PREVENTING AND/OR INHIBITING VIRAL INFECTION AND SPREAD
    Publication number: 20220040265
    Abstract: Use of an interferon (INF), whether Type I (e.g. interferon-alpha, interferon-beta, etc.), Type II (e.g. interferon-gamma) and/or Type III (e.g. interferon-lamda), for inhibiting and/or preventing coronavirus infection in people, including but not limited to those people at risk of exposure to COVID 19 and/or variants thereof.
    Type: Application
    Filed: August 5, 2021
    Publication date: February 10, 2022
    Inventor: Peter G. Carroll
  • Decontaminating clinical samples
    Patent number: 5665762
    Abstract: The present invention contemplates methods of decontaminating human fluids prior to processing in the clinical laboratory. The techniques handle large volumes of human serum without impairing the testing results. Novel compounds for photodecontaminating biological material are also contemplated which are compatible with clinical testing, in that they do not interfere with serum analytes.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: September 9, 1997
    Assignee: Carus Corporation
    Inventors: Peter G. Carroll, Stephen T. Isaacs, George D. Cimino
  • Aminopsoralen compounds for use in decontaminating clinical samples
    Patent number: 5582994
    Abstract: The present invention contemplates methods of decontaminating human fluids prior to processing in the clinical laboratory. The techniques handle large volumes of human serum without impairing the testing results. Novel compounds for photodecontaminating biological material are also contemplated which are compatible with clinical testing, in that they do not interfere with serum analytes.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 10, 1996
    Assignee: Steritech, Inc.
    Inventors: Peter G. Carroll, Stephen T. Isaacs, George D. Cimino
  • Inactivation of pathogens in clinical samples
    Patent number: 5556958
    Abstract: The present invention contemplates methods of decontaminating human fluids prior to processing in the clinical laboratory. The techniques handle large volumes of human serum without impairing the testing results. Novel compounds for photodecontaminating biological material are also contemplated which are compatible with clinical testing, in that they do not interfere with serum analytes.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: September 17, 1996
    Assignee: Steritech, Inc.
    Inventors: Peter G. Carroll, Stephen T. Isaacs, George D. Cimino